The document discusses the history of polio and polio vaccines such as the inactivated polio vaccine (IPV) and oral polio vaccine (OPV). It notes that while OPV has helped reduce polio cases globally, ongoing issues with OPV include vaccine-derived polio viruses and vaccine-associated paralysis. The document advocates for the increased use of IPV to address these issues and aid in the final push to eradicate polio globally.